Optimal Conditions for Adenoviral Transduction of Immature Dendritic Cells Without Affecting the Tolerogenic Activity of DC-Based Immunotherapy

J Virol Methods. 2024 Mar 27:114921. doi: 10.1016/j.jviromet.2024.114921. Online ahead of print.ABSTRACTDendritic cells (DCs) play a pivotal role in maintaining immune tolerance. Using recombinant adenovirus (rAd) to deliver vectors to immature dendritic cells (imDCs) is an important method for studying the tolerogenic function of DCs. We found that using RPMI medium and a higher MOI during transduction increased the expression of CD80, CD86, and MHC-II on the surface of imDCs. Our data reveal a significant increase in the secretion of the pro-inflammatory cytokine IL-6 in the group showing the most pronounced phenotypic changes. In the mouse heart transplant model, imDCs with unstable phenotype and function due to adenoviral transduction resulted in an increased proportion of Th1 and Th17 cells in recipients. However, these effects can be managed, and our proposed optimized transduction strategy significantly minimizes these adverse effects. Our study holds significant implications for the development and optimization of immunotherapy utilizing tolerogenic dendritic cells.PMID:38552881 | DOI:10.1016/j.jviromet.2024.114921
Source: Journal of Virological Methods - Category: Virology Authors: Source Type: research